ARCHIVES

Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says

This article is from The Cancer Letter archive.

Vol. 24 No. 07 | February 20, 1998

Download PDF Visit The Full Archive

Related Articles

AVEO’s Tizozanib Fails in Colorectal Cancer

January 10, 2014

NCI Offers Mouse Strains, Tissue Microarrays, Online.

March 9, 2001

CPSC Relies On NCI Findings For New Policy

July 21, 1978

Trial Data: No Benefit In Adding Perifosine to Capecitabine

June 29, 2012

In Brief: Maguire Wants Five Environmental Experts In Addition To Those On The Board

February 16, 1979

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

December 31, 2010